Summit Trail Advisors’s Labcorp LH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.54M Buy
5,779
+800
+16% +$217K 0.02% 707
2025
Q4
$1.25M Buy
4,979
+1,778
+56% +$472K 0.02% 687
2025
Q3
$919K Buy
3,201
+1,621
+103% +$434K 0.01% 879
2025
Q2
$415K Buy
+1,580
New +$385K 0.01% 800
2024
Q4
Sell
-1,223
Closed -$273K 603
2024
Q3
$273K Sell
1,223
-31
-2% -$6.81K 0.01% 577
2024
Q2
$255K Buy
1,254
+142
+13% +$28.9K 0.01% 527
2024
Q1
$243K Buy
1,112
+31
+3% +$6.83K 0.01% 520
2023
Q4
$246K Buy
1,081
+74
+7% +$15.5K 0.01% 446
2023
Q3
$202K Sell
1,007
-135
-12% -$28.5K 0.01% 500
2023
Q2
$237K Buy
1,142
+120
+12% +$23.3K 0.01% 431
2023
Q1
$201K Buy
+1,022
New +$210K 0.01% 388
2018
Q4
Sell
-932
Closed -$139K 174
2018
Q3
$139K Buy
932
+280
+43% +$42.6K 0.03% 224
2018
Q2
$101K Buy
+652
New +$98.4K 0.04% 214
2018
Q1
Sell
-1,259
Closed -$188K 1130
2017
Q4
$188K Buy
+1,259
New +$166K 0.02% 440

Other funds holding LH

Summit Trail Advisors's LH Position: Q1 2026 in Review

Summit Trail Advisors increased its Labcorp (LH) stake by 16% in Q1 2026, buying an estimated $217K and bringing the position to 5,779 shares worth $1.54M. The position accounts for 0.02% of the portfolio, ranked #707.

Summit Trail Advisors first reported a position in LH in Q4 2017 and has held it in 14 quarters since. 1,031 funds tracked by Wall St. Rank hold LH as of Q1 2026.

  • Summit Trail Advisors held 5,779 shares of Labcorp worth $1.54M as of Q1 2026.
  • Summit Trail Advisors bought 800 Labcorp shares in Q1 2026, an estimated $217K.
  • Labcorp made up 0.02% of Summit Trail Advisors's portfolio in Q1 2026, its #707 holding.
  • Summit Trail Advisors first reported a position in Labcorp in Q4 2017 and has held it in 14 quarters since.
  • 1,031 funds tracked by Wall St. Rank held Labcorp as of Q1 2026.

Based on Summit Trail Advisors's 13F filing for Q1 2026, filed 12 May 2026.